TYRA Stock Summary and Trading Ideas (Tyra Biosciences | NASDAQ:TYRA)

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Tyra Biosciences trades on the NASDAQ stock market under the symbol TYRA.

As of December 19, 2025, TYRA stock price climbed to $25.51 with 1,932,439 million shares trading.

TYRA has a beta of 1.52, meaning it tends to be more sensitive to market movements. TYRA has a correlation of 0.17 to the broad based SPY ETF.

TYRA has a market cap of $1.36 billion. This is considered a Small Cap stock.

In the last 3 years, TYRA traded as high as $29.60 and as low as $6.42.

The top ETF exchange traded funds that TYRA belongs to (by Net Assets): VTI, IWM, VXF, IBB, IWN.

TYRA has outperformed the market in the last year with a price return of +75.9% while the SPY ETF gained +18.1%. TYRA has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +104.1% and +18.7%, respectively, while the SPY returned +2.8% and -0.5%, respectively.

TYRA support price is $21.91 and resistance is $24.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TYRA shares will trade within this expected range on the day.